Asia-Pacific Cannabidiol (CBD) Market, By Source (Hemp And Marijuana), Grade (Food Grade And Therapeutics Grade), Nature (Organic And Inorganic), Application (Tincture, Food, Beverages, Pharmaceutical, Topicals, Dietary Supplements And Others), Product Type (CBD Oil, CBD Concentrates, CBD Isolates And Others) - Industry Trends and Forecast to 2029.
Asia-Pacific Cannabidiol (CBD) Market Analysis and Insights
Asia-Pacific cannabidiol (CBD) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 24.1% in the forecast period of 2022 to 2029. Technological advancements in cannabidiol (CBD) drug treatments, rise in the healthcare sector are another factors drive growth of the Asia-Pacific cannabidiol (CBD) market in the forecast period.
However, side effects associated with CBD oil and counterfeit and synthetic products available in the market will restraining the market growth. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of Asia-Pacific cannabidiol (CBD) market.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 |
|
Quantitative Units |
Revenue in USD Million, Pricing in USD |
|
Segments Covered |
By Source (Hemp And Marijuana), Grade (Food Grade And Therapeutics Grade), Nature (Organic And Inorganic), Application (Tincture, Food, Beverages, Pharmaceutical, Topicals, Dietary Supplements And Others), Product Type (CBD Oil, CBD Concentrates, CBD Isolates And Others |
|
Countries Covered |
China, Japan, India, South Korea, Thailand, Malaysia, Australia, New Zealand and rest of Asia-Pacific |
|
Market Players Covered |
Some of the key players operating in the Asia-Pacific cannabidiol (CBD) market are CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE’S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads among others. |
Cannabidiol (CBD) Market Definition
Cannabidiol (CBD) is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content. It has several benefits in treating anxiety and seizures and reducing pain. Due to its healing properties, the demand for CBD for health and wellness purposes is high, which is the major factor driving the market. Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the Asia-Pacific market is anticipated to grow at a lucrative rate over the forecast period. Cannabidiol oil is increasingly being used to make skincare products to treat acne and wrinkles. Sephora, for example, had recently introduced cannabidiol or CBD skincare line to its stores. Similarly, Ulta Beauty is intending to launch a cannabidiol-based product line. Several new companies are also entering the market for cannabidiol-infused cosmetic products.
Furthermore, the government of different countries as well as major players in the cannabinoid market are investing in research and development activities. The CBD is said to be an effective treatment for various neurological diseases including epilepsy in several clinical trials.
Market Dynamics
Drivers
- Increasing demand for CBD in health & fitness
Rising awareness among consumers regarding health and fitness will help CBD market to witness rapid growth. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in this sector.
Moreover, CBD products are used to relieve various problems such as anxiety/ stress, sleep/insomnia, chronic pain, migraine, skin care, seizures, joint pain & inflammation, neurological conditions, and many others. The chronic pain treatment has gained much popularity due to additional benefits offered by CBD when used. There has been increasing demand for cannabidiol (CBD) products over recent years owing to its widespread medical applications and pain relief treatment. CBD helps in reducing chronic pain by acting on variety of biological process in the body. In addition, CBD possesses antioxidant, anti-inflammatory and analgesic properties. Therefore, CBD products reduces the anxiety that is experienced by the people suffering from the chronic pain. Thus, the increasing demand for CBD in the treatment of chronic pain is augmenting the market to grow. This also help people to maintain their health and fitness routines, while staying away from pain that may occur during fitness activities.
- Improving government approvals and regulations for CBD products
There are strict government regulations and CBD based products required strict approvals before they were marketed and supplied in the local as well international market, which limited the growth of the market. However, with time these restrictions have been eased up and there has been increasing acceptance of refined CBD products combined with the increasing legalization of marijuana and marijuana-derived products for various applications. This will drive the growth and demand in the market.
Moreover, there is the presence of major manufacturers of CBD products across the globe which has further induced the government and other regulatory bodies such as Food and Drug Administration (F.D.A.) in the U.S., European Union in Europe, etc. to ease up the restrictions for CBD and CBD based products.
Restraint
-
High cost of CBD products
CBD is a popular and a holistic choice for people struggling with pain, inflammation, and sleep problems. Since CBD is a new product with less research and development and has lately been regulated and approved, therefore, the price of CBD are subject to fluctuations. The production of hemp became legal in 2018, which affected the price of CBD products. As a result, various CBD products witnessed some price inflation.
Moreover, many farmers are transitioning towards growing and selling hemp used to make CBD products, but despite the increased popularity of this product, it presents its own agricultural challenges. Firstly, switching over to a new crop results in new expenses. The most efficient way to harvest hemp is using a combine harvester. However, farmers who have previously grown crops that don’t require combines, such as strawberries, can’t afford to purchase a combine right away. Therefore, they need to hire people to help harvest the hemp, which drives up overall product prices as the raw material becomes costly.
Additionally, hemp requires more time and labor to grow and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD need to use either ethanol or supercritical carbon dioxide (CO2 extraction). The extraction and refinement process requires special machinery and takes a long time, which drives up the CBD cost. Thus, all these factors add up to the costs of CBD products making them much more costly than other products, which is likely to restrain the market’s demand.
Opportunity
-
Increasing investments in development of new CBD based products
With the increasing trend of providing innovative and refined products in the market, manufacturers are spending large amounts in research and development for the production of new CBD based products. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand.
The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products in turn providing opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.
Moreover, with the ease in regulations and post the approval of cannabis products, the companies are investing huge amounts in the product development and upgrading the raw material production, which will also help them to cut down on costs while meeting the surging demand in the market. The new product development and increasing research and development activities along with various strategic decisions taken by key manufacturers in the market will offer lucrative opportunity for the growth of the Asia-Pacific CBD market.
Challenge
- Side effects associated with CBD oil
Cannabidiol is well-known for its ability to cure a variety of illnesses, including anxiety, seizures, neurological problems, cancer-related nausea, chronic pain, and more. However, being useful for a variety of medical illnesses, various studies and research conducted by numerous organizations have shown that CBD-based medicines can have negative effects as well.
Some of the side effects that are commonly experienced by consumers include dry mouth, drowsiness, low blood pressure, and lightheadedness. CBD is also known to raise the level of Coumadin (a blood thinner) in the body, which can interact with other drugs and cause negative side effects. These factors might impede future adoption of CBD for therapeutic purposes.
Moreover, another cause for concern is the unreliability of the purity and dosage of CBD in products such as CBD oil. High concentration of CBD oil can also have harmful effects on the consumers’ health. In some cases, excessive use of CBD oil may also increase liver enzymes, which is a marker of liver inflammation. Cytochrome P450 (CYP450) is an enzyme which body uses to break down some drugs. CBD oil can block CYP450. That means that taking CBD oil with these drugs could make them have a stronger effect than one needs or make them not work at all.
Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may pose as a challenge for the increasing demand of CBD products in the Asia-Pacific CBD market.
Post COVID-19 Impact on Asia-Pacific Cannabidiol (CBD) Market
COVID-19 has resulted in a substantial upsurge in demand for medical supplies from both healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the Asia-Pacific cannabidiol (CBD) market.
Asia-Pacific Cannabidiol (CBD) Market Scope and Market Size
Asia-Pacific cannabidiol (CBD) market is segmented on the basis source, grade, application, product type, nature. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the Difference in your target markets.
BY SOURCE
- HEMP
- MARIJUANA
On the basis of source, the Asia-Pacific cannabidiol (CBD) market is segmented into hemp and marijuana.
BY PRODUCT TYPE
- CBD OIL
- CBD ISOLATES
- CBD CONCENTRATES
- OTHERS
On the basis of product type, the Asia-Pacific cannabidiol (CBD) market is segmented into CBD oil, CBD concentrates, CBD isolates and others
BY NATURE
- ORGANIC
- INORGANIC
On the basis of nature, the Asia-Pacific cannabidiol (CBD) market is segmented into organic and inorganic.
BY GRADE
- FOOD GRADE
- THERAPEUTIC GRADE
On the basis of grade, the Asia-Pacific cannabidiol (CBD) market is segmented into food grade and therapeutics grade.
BY APPLICATION
- Tincture
- Food
- Beverages
- Pharmaceutical
- Topicals
- Dietary supplements
- Others
On the basis of application, the Asia-Pacific cannabidiol (CBD) market is segmented into tincture, food, beverages, pharmaceutical, topicals, dietary supplements and others.
Asia-Pacific Cannabidiol (CBD) Market Country Level Analysis
The cannabidiol (CBD) market is analyzed and market size information is provided by source, grade, application, product type, nature.
The countries covered in the cannabidiol (CBD) market report are China, Japan, India, South Korea, Thailand, Malaysia, Australia, New Zealand and rest of Asia-Pacific.
In 2022, China is dominating due to the presence of key market players along the largest consumer market with high GDP. China is expected to grow due to rise in technological advancement in drug treatments.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Cannabidiol (CBD) market also provides you with detailed market analysis for every country growth in healthcare industry. Moreover, it provides detailed information regarding healthcare services and treatments, impact of regulatory scenarios, and trending parameters regarding cannabidiol (CBD) market.
Competitive Landscape and Asia-Pacific Cannabidiol (CBD) Market Share Analysis
Asia-Pacific cannabidiol (CBD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cannabidiol (CBD) products.
The major companies which are dealing in the cannabidiol (CBD) market are CV Sciences, Inc., VIVO Cannabis Inc., Gaia Herbs Hemp, Phoena Holdings Inc., Medical Marijuana, Inc., The Cronos Group, CHARLOTTE’S WEB, HEXO Corp., Aurora Cannabis, Canopy Growth Corporation, Jazz Pharmaceuticals, Inc., Tilray, Curaleaf, KAZMIRA, Freedom Leaf, Inc., Koi CBD, Groff North America Hemplex, Joy Organics, Elixinol Wellness Limited, Isodiol International Inc., Healthy Food Ingredients, LLC, NuLeaf Naturals, LLC, Diamond CBD, Medterra CBD, ENDOCA, Green Roads among others.
Strategic alliances like mergers, acquisitions and agreement by the key market players are further expected to accelerate the growth of cannabidiol (CBD) products.
For instance,
- In May, 2022, Canopy Growth Corporation and Lemurian, Inc., a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology, announced that they have entered into definitive agreements providing Canopy Growth, by way of a wholly-owned subsidiary, the right to acquire, upon federal permissibility of THC in the U.S. or earlier at Canopy Growth’s election, up to 100% of the outstanding capital stock of Jetty.This has helped the company to expand their business in market.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC CANNABIDIOL (CBD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 BENCHMARKING ANALYSIS
4.2 CBD PRODUCTS, INCLUDING CANNABINOIDS (IN %)
4.3 CBD RAW MATERIAL DEVELOPMENT TREND
4.3.1 MORE CONTROLLED CBD LEVELS:
4.3.2 CBD AND GENETICS:
4.3.3 ADVANCEMENTS MADE IN EXTRACTION:
4.3.4 NANOTECHNOLOGY
4.3.5 CONCLUSION
4.4 COMPANY POSITIONING GRID
4.4.1 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: COMPANY LANDSCAPE
4.4.1.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
4.4.1.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
4.4.1.3 COMPANY SHARE ANALYSIS: EUROPE
4.4.1.4 COMPANY SHARE ANALYSIS: SOUTH AMERICA
4.4.2 COMPANY’S CURRENT VENDORS
4.5 OVERALL VOLUME (KILO TONS) & QUANTITY OF COMPLETED TRANSACTIONS: ASIA PACIFIC CANNABIDIOL (CBD) MARKET
4.6 LIST OF COUNTRIES THAT LEGALIZED CANNABIDIOL (CBD)
4.7 REGULATION COVERAGE
4.8 IMPORT & EXPORT REGULATION
4.8.1 IMPORT REGULATIONS
4.8.2 EXPORT REGULATIONS
4.9 IMPORT STANDARDS
4.1 GOVERNMENT POLICIES
4.11 QUALIFICATION/CERTIFICATION REQUIRED
4.12 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: PRICING ANALYSIS & DEAL PRICING
4.13 RAW MATERIAL EXTRACTOR POSITIONING GRID
4.13.1 KEY EXTRACTION
4.13.2 LINE CAPABILITY
4.14 TECHNOLOGICAL ADVANCEMENTS:
4.15 VENDOR/ DISTRIBUTOR SHARE ANALYSIS
4.16 VENDOR/DISTRIBUTOR KEY BUYERS
5 CLIMATE CHANGE SCENARIO: ASIA PACIFIC CANNABIDIOL (CBD) MARKET
5.1 ENVIRONMENT CONCERNS-
5.2 INDUSTRY RESPONSE-
5.3 GOVERNMENT INITIATIVES
5.4 ANALYST RECOMMENDATIONS
6 SUPPLY CHAIN OF THE ASIA PACIFIC CANNABIDIOL (CBD) MARKET
6.1 LOGISTIC COST SCENARIO
6.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN DEMAND FOR CBD IN HEALTH & FITNESS
7.1.2 IMPROVING GOVERNMENT APPROVALS AND REGULATIONS FOR CBD PRODUCTS
7.1.3 THERAPEUTIC PROPERTIES OF CBD OIL
7.1.4 CONSUMERS' SHIFT TOWARDS LEGALLY PURCHASING CANNABIS FOR MEDICAL AS WELL AS RECREATIONAL USE
7.2 RESTRAINTS
7.2.1 HIGH COST OF CBD PRODUCTS
7.2.2 AVAILABILITY OF COUNTERFEIT AND SYNTHETIC PRODUCTS IN THE MARKET
7.3 OPPORTUNITIES
7.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF NEW CBD BASED PRODUCTS
7.3.2 GROWING MEDICAL APPLICATIONS OF CBD
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH CBD OIL
7.4.2 BARRIERS IN TERMS OF MARKETING OF CBD
8 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY SOURCE
8.1 OVERVIEW
8.2 HEMP
8.3 MARIJUANA
9 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 CANNABIDIOL (CBD) OIL
9.2.1 CARBON DIOXIDE EXTRACTION
9.2.2 STEAM DISTILLATION
9.2.3 SOLVENT EXTRACTION
9.2.4 OTHERS
9.3 CANNABIDIOL (CBD) ISOLATES
9.4 CANNABIDIOL (CBD) CONCENTRATES
9.5 OTHERS
10 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY NATURE
10.1 OVERVIEW
10.2 ORGANIC
10.3 INORGANIC
11 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY GRADE
11.1 OVERVIEW
11.2 FOOD GRADE
11.3 THERAPEUTIC GRADE
12 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 TINCTURE
12.3 FOOD
12.3.1 CHOCOLATE & CONFECTIONERY
12.3.1.1 CANDY
12.3.1.2 CHOCOLATE
12.3.1.3 CHEWS
12.3.1.4 GUMMIES
12.3.1.5 OTHERS
12.3.2 HONEY
12.3.3 DAIRY BASED EDIBLE
12.3.3.1 MILK
12.3.3.2 ICE CREAM
12.3.3.3 OTHERS
12.3.4 SAUCES AND SEASONINGS
12.3.5 BAKERY EDIBLE
12.3.5.1 COOKIES AND BISCUITS
12.3.5.2 BROWNIES
12.3.5.3 OTHERS
12.3.6 OTHERS
12.3.7 PHARMACEUTICALS
12.3.7.1 DRAVET SYNDROME
12.3.7.2 MULTIPLE SCLEROSIS DRUG APPLICATIONS
12.3.7.3 NEUROLOGICAL DRUG APPLICATIONS
12.3.7.4 CANCER DRUG APPLICATIONS
12.3.7.5 OTHERS
12.3.8 DIETARY SUPPLEMENTS
12.3.8.1 CAPSULES
12.3.8.2 GUMMIES
12.3.8.3 OTHERS
12.3.9 BEVERAGES
12.3.9.1 NON-ALCOHOLIC BEVERAGES
12.3.9.1.1 ENERGY DRINKS
12.3.9.1.2 SOFT DRINKS
12.3.9.1.3 RTD COFFEE
12.3.9.1.4 TEA
12.3.9.1.5 SPARKLING WATER
12.3.9.1.6 OTHERS
12.3.9.2 FLAVORED DRINKS
12.3.9.2.1 ORANGE
12.3.9.2.2 LEMON
12.3.9.2.3 BERRIES
12.3.9.2.4 COCONUT
12.3.9.2.5 OTHERS
12.3.9.3 ALCOHOLIC BEVERAGES
12.3.9.3.1 BEER
12.3.9.3.2 WINE
12.3.9.3.3 OTHERS
12.3.9.4 OTHERS
12.3.10 TOPICAL
12.3.10.1 LOTION
12.3.10.2 SALVE
12.3.10.3 LIP BALM
12.3.10.4 OTHERS
12.3.11 OTHERS
12.3.11.1 VAPES
12.3.11.2 CIGARETTES
12.3.11.3 SPA AND RECREATION
13 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 AUSTRALIA
13.1.4 INDIA
13.1.5 THAILAND
13.1.6 MALAYSIA
13.1.7 SOUTH KOREA
13.1.8 NEW ZEALAND
13.1.9 REST OF ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 CURALEAF
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 TILRAY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 JAZZ PHARMACEUTICALS, INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 CANOPY GROWTH CORPORATION
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 AURORA CANNABIS.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 CHARLOTTE’S WEB.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 CV SCIENCES, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 DIAMOND CBD.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 ELIXINOL WELLNESS LIMITED
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 ENDOCA.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 FREEDOM LEAF, INC
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 GAIA HERBS HEMP
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 GREEN ROADS.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 GROFF NORTH AMERICA HEMPLEX
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 HEXO CORP.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 HEALTHY FOOD INGREDIENTS, LLC.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 ISODIOL INTERNATIONAL INC
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 JOY ORGANICS
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 KAZMIRA
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 KOI CBD
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 MEDICAL MARIJUANA, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 EVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 MEDTERRA CBD
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 NULEAF NATURALS, LLC
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 PHOENA HOLDINGS INC.
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 THE CRONOS GROUP
15.25.1 COMPANY SNAPSHOT
15.25.2 REVENUE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENTS
15.26 VIVO CANNABIS INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 REVENUE ANALYSIS
15.26.3 PRODUCT PORTFOLIO
15.26.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Lista de Tablas
TABLE 1 BENCHMARK ANALYSIS
TABLE 2 AVERAGE VOLUME TREND FOR ASIA PACIFIC CANNABIDIOL (CBD) MARKET (KILO TONS)
TABLE 3 THE FOLLOWING ARE THE PRICES OF PRODUCTS OFFERED BY THE COMPANIES:
TABLE 4 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC HEMP IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC MARIJUANA IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC CANNABIDIOL (CBD) ISOLATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC CANNABIDIOL (CBD) CONCETRATES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC ORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC INORGANIC IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC FOOD GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC THERAPEUTIC GRADE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC TINCTURE IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC FOOD IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC FOOD IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC PHARMACEUTICALS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC TOPICAL IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC TOPICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN CANNABIDIOL (CBD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 44 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 45 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 46 ASIA-PACIFIC FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 ASIA-PACIFIC CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 48 ASIA-PACIFIC BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 ASIA-PACIFIC DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 50 ASIA-PACIFIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 51 ASIA-PACIFIC ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 52 ASIA-PACIFIC NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 ASIA-PACIFIC FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 ASIA-PACIFIC PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 ASIA-PACIFIC TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 56 ASIA-PACIFIC DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 57 ASIA-PACIFIC OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 CHINA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 59 CHINA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 CHINA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 61 CHINA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 62 CHINA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 63 CHINA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 CHINA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 65 CHINA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 66 CHINA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 CHINA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 CHINA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 CHINA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 CHINA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 71 CHINA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 72 CHINA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 73 CHINA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 74 CHINA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 CHINA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 JAPAN CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 77 JAPAN CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 78 JAPAN CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 79 JAPAN CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 80 JAPAN CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 81 JAPAN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 82 JAPAN FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 JAPAN CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 84 JAPAN BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 85 JAPAN DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 86 JAPAN BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 87 JAPAN ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 JAPAN NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 JAPAN FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 90 JAPAN PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 JAPAN TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 JAPAN DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 JAPAN OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 94 AUSTRALIA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 95 AUSTRALIA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 96 AUSTRALIA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 97 AUSTRALIA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 98 AUSTRALIA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 99 AUSTRALIA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 100 AUSTRALIA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 AUSTRALIA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 AUSTRALIA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 AUSTRALIA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 AUSTRALIA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 105 AUSTRALIA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 106 AUSTRALIA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 107 AUSTRALIA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 108 AUSTRALIA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 AUSTRALIA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 AUSTRALIA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 111 AUSTRALIA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 112 INDIA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 113 INDIA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 114 INDIA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 115 INDIA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 116 INDIA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 117 INDIA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 118 INDIA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 119 INDIA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 120 INDIA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 121 INDIA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 122 INDIA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 INDIA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 INDIA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 INDIA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 126 INDIA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 127 INDIA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 128 INDIA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 129 INDIA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 130 THAILAND CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 131 THAILAND CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 132 THAILAND CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 133 THAILAND CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 134 THAILAND CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 135 THAILAND CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 136 THAILAND FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 137 THAILAND CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 138 THAILAND BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 139 THAILAND DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 140 THAILAND BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 141 THAILAND ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 142 THAILAND NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 143 THAILAND FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 144 THAILAND PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 145 THAILAND TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 146 THAILAND DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 147 THAILAND OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 148 MALAYSIA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 149 MALAYSIA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 150 MALAYSIA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 151 MALAYSIA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 152 MALAYSIA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 153 MALAYSIA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 154 MALAYSIA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 155 MALAYSIA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 156 MALAYSIA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 157 MALAYSIA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 158 MALAYSIA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 159 MALAYSIA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 160 MALAYSIA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 161 MALAYSIA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 162 MALAYSIA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 163 MALAYSIA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 164 MALAYSIA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 165 MALAYSIA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 SOUTH KOREA CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 167 SOUTH KOREA CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 168 SOUTH KOREA CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 169 SOUTH KOREA CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 170 SOUTH KOREA CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 171 SOUTH KOREA CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 172 SOUTH KOREA FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 173 SOUTH KOREA CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 174 SOUTH KOREA BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 175 SOUTH KOREA DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 176 SOUTH KOREA BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 177 SOUTH KOREA ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 178 SOUTH KOREA NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 179 SOUTH KOREA FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 180 SOUTH KOREA PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 181 SOUTH KOREA TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 182 SOUTH KOREA DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 183 SOUTH KOREA OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 184 NEW ZEALAND CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 185 NEW ZEALAND CANNABIDIOL (CBD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 186 NEW ZEALAND CANNABIDIOL (CBD) OIL IN CANNABIDIOL (CBD) MARKET, BY EXTRACTION METHOD, 2020-2029 (USD MILLION)
TABLE 187 NEW ZEALAND CANNABIDIOL (CBD) MARKET, BY NATURE, 2020-2029 (USD MILLION)
TABLE 188 NEW ZEALAND CANNABIDIOL (CBD) MARKET, BY GRADE, 2020-2029 (USD MILLION)
TABLE 189 NEW ZEALAND CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 190 NEW ZEALAND FOOD IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 191 NEW ZEALAND CHOCOLATE & CONFECTIONERY IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 192 NEW ZEALAND BAKERY EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 193 NEW ZEALAND DAIRY BASED EDIBLE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 194 NEW ZEALAND BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 195 NEW ZEALAND ALCOHOLIC BEVERAGE IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 196 NEW ZEALAND NON-ALCOHOLIC BEVERAGES IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 197 NEW ZEALAND FLAVORED DRINKS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 198 NEW ZEALAND PHARMACEUTICAL IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 199 NEW ZEALAND TOPICALS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 200 NEW ZEALAND DIETARY SUPPLEMENTS IN CANNABIDIOL (CBD) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 201 NEW ZEALAND OTHERS IN CANNABIDIOL (CBD) MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 202 REST OF ASIA-PACIFIC CANNABIDIOL (CBD) MARKET, BY SOURCE, 2020-2029 (USD MILLION)
Lista de figuras
FIGURE 1 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC CANNABIDIOL (CBD) MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 THE INCREASING DEMAND FOR CANNABIDIOL (CBD) DUE TO ITS HEALING PROPERTIES AND HEALTH AND WELLNESS PURPOSES IS HIGH, WHICH IS THE MAJOR FACTOR DRIVING THE MARKET IS EXPECTED TO DRIVE THE ASIA PACIFIC CANNABIDIOL (CBD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 HEMP IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CANNABIDIOL (CBD) MARKET IN 2022 & 2029
FIGURE 13 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 14 NORTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 15 EUROPE CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 16 SOUTH AMERICA CANNABIDIOL (CBD) MARKET: COMPANY SHARE 2021 (%)
FIGURE 17 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: VENDOR/ DISTRIBUTOR SHARE ANALYSIS (%)
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC CANNABIDIOL (CBD) MARKET
FIGURE 19 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY SOURCE, 2021
FIGURE 20 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY SOURCE, 2022-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY SOURCE, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2021
FIGURE 24 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY NATURE, 2021
FIGURE 28 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY NATURE, 2022-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY NATURE, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY NATURE, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY GRADE, 2021
FIGURE 32 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY GRADE, 2022-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY GRADE, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY GRADE, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2021
FIGURE 36 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 37 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 38 ASIA PACIFIC CANNABIDIOL (CBD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET: SNAPSHOT (2021)
FIGURE 40 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021)
FIGURE 41 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 ASIA-PACIFIC CANNABIDIOL (CBD) MARKET: BY SOURCE (2022-2029)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
